Sarepta Therapeutics | SRPT - PE Price to Earnings


Sarepta Therapeutics reported 27.27 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen 25.31 15.82 Dec/2025
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
Biogen 14.02 4.63 Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Capricor Therapeutics 2.76K 2.76K Dec/2022
Daiichi Sankyo 20.73 1.74 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Gilead Sciences 15.63 0.08 Dec/2025
Incyte 14.84 2.79 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Moderna 27.22 14.51 Jun/2023
Neurocrine Biosciences 835.47 802.2 Dec/2025
Novavax 2.01 1.07 Dec/2025
Pfizer 14.48 5.18 Dec/2025
PTC Therapeutics 9.98 3.25 Dec/2025
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sanofi 11.99 1.58 Dec/2025
Sarepta Therapeutics 27.27 0 Sep/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Vertex Pharmaceuticals 26.15 2.22 Dec/2025